TrialHaematologica2017

Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study.

Delphine Rea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.